Allergic rhinoconjunctivitis with or without controlled asthma research hub

Clinical trial to evaluate the efficacy and safety of two concentrations (1000DPP/ml and 3000DPP/ml) of depigmented polymerized allergen extracts of Depigoid GrassMix / Depigoid FORTE GrassMix compared to placebo, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma due to clinically relevant sensitization to grass pollen

This study is testing different doses of a new hay fever treatment called Depigoid GrassMix. It's for adults with hay fever, with or without mild asthma triggered by grass pollen. We want to see if the treatment helps reduce symptoms and the need for medication.